Published in Echocardiography on August 01, 2009
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol (2014) 1.87
Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg (2011) 1.60
Rescue percutaneous coronary intervention for graft failure immediately after coronary artery bypass grafting: case report and review of literature. J Card Surg (2008) 1.39
Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke (2011) 1.38
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation (2013) 1.28
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis (2012) 1.21
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. Atherosclerosis (2011) 1.18
Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J (2009) 1.14
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem (2013) 1.06
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol (2009) 1.01
Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. J Clin Lipidol (2011) 0.96
Association between statins and infections after coronary artery bypass grafting. Int J Cardiol (2012) 0.95
Impact of clinical complexity on the quality of diabetes care. Am J Manag Care (2012) 0.93
Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke (2013) 0.91
Cor triatriatum dexter. Tex Heart Inst J (2007) 0.90
Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. J Am Geriatr Soc (2012) 0.87
The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (2012) 0.87
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. J Lipid Res (2012) 0.87
Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail (2013) 0.87
Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men. Am J Cardiol (2005) 0.85
Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol (2012) 0.84
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J (2011) 0.83
Medicare eligibility and physician utilization among adults with coronary heart disease and stroke. Med Care (2012) 0.83
Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? Methodist Debakey Cardiovasc J (2013) 0.82
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease. J Clin Lipidol (2012) 0.82
Segmental analysis of carotid arterial strain using speckle-tracking. J Am Soc Echocardiogr (2011) 0.81
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis (2013) 0.81
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. J Vasc Surg (2011) 0.81
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy. J Lipid Res (2013) 0.81
Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol (2013) 0.80
Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records. Med Care (2015) 0.80
Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther (2013) 0.80
One-year outcomes associated with using observation services in triaging patients with nonspecific chest pain. Clin Cardiol (2014) 0.80
Revisiting the economic efficiencies of observation units. Manag Care (2015) 0.80
Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry. J Am Coll Cardiol (2016) 0.79
Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr (2011) 0.79
Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. Magn Reson Imaging (2011) 0.79
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol (2012) 0.79
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years. Am J Cardiol (2013) 0.78
Impact of colchicine on pericardial inflammatory syndromes--an analysis of randomized clinical trials. Int J Cardiol (2012) 0.78
Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol (2012) 0.78
Contrast echocardiography for right-sided heart conditions: case reports and literature review. Tex Heart Inst J (2008) 0.77
Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. J Am Soc Echocardiogr (2013) 0.77
Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol (2014) 0.76
Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging. Clin Cardiol (2015) 0.75
Reply: Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. J Am Coll Cardiol (2014) 0.75
Novel therapies for treating familial hypercholesterolemia. Curr Atheroscler Rep (2014) 0.75
Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region. J Cardiovasc Pharmacol (2015) 0.75
Acute Aortic Valve Rupture From Infective Endocarditis After Transrectal Prostate Biopsy: A Call to Revise the AHA Guidelines for Prevention of Infective Endocarditis. Clin Med Insights Case Rep (2013) 0.75
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. Tex Heart Inst J (2016) 0.75
ST elevation: telling pathology from the benign patterns. Glob J Health Sci (2012) 0.75
Cardiac sarcoidosis: a clinical entity uncommonly recognized. Tex Heart Inst J (2009) 0.75
Efficacy and tolerability of multidrug therapy for hypertriglyceridemia. J Clin Lipidol (2009) 0.75
The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia. Curr Atheroscler Rep (2015) 0.75
Update on therapies targeting HDL: the mystery continues. Curr Opin Lipidol (2011) 0.75
Noncardiac surgery following percutaneous coronary intervention. Catheter Cardiovasc Interv (2004) 0.75
Lipid management: considerations in acute coronary syndrome. Curr Atheroscler Rep (2009) 0.75
Association of Internet Use With the Use of Addictive Substances in The United States. Am J Cardiol (2020) 0.75
Lipid management: considerations in acute coronary syndrome. Curr Cardiol Rep (2008) 0.75
Understanding Self-regulation Behaviors in South Asians With Coronary Artery Disease: A Mixed-Methods Study. J Cardiovasc Nurs (2016) 0.75
Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology. JACC Cardiovasc Imaging (2015) 0.75
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future. Curr Opin Lipidol (2010) 0.75